Public, Cancer Screening and Prevention

Aidot participates in RSNA 2023 and presents Cerviray cervical cancer diagnosis solutions, etc.

Aidot participates in RSNA 2023 and presents Cerviray cervical cancer diagnosis solutions, etc. 1
28
Nov

This story originally appeared on NAVER.COM. *Minor edits have been made by the CerviQ editors.

Aidot (CEO Jaehoon Jeong) announced that it will participate in the Society of Radiology of North America 2023 (RSNA2023), which will be held in Chicago, USA from November 26 to November 29, 2023, and showcase Aidot’s various artificial intelligence solutions.

RSNA is the largest radiology society in North America that shares cutting-edge medical technology and innovative research results. It is a long-standing society with more than 600 companies participating and over 400 seminars and educational programs.

At this conference, Aidot announced that it plans to showcase various self-developed diagnostic AI solutions. Among them, we announced the full-fledged entry into the U.S. market of Gigadot AI, a real-time gastroscopy diagnosis AI solution that recently received grade 3 approval from the Ministry of Food and Drug Safety, and Colondot AI, a colonoscopy diagnosis AI solution. Surviray AI and FDA 510 (FDA 510), which already have partners around the world, Six types of solutions will be exhibited, including the US-bound Cerviray AI that has secured registration.

In particular, in the case of Cerviray AI destined for the United States, it was announced that insurance claims can already be made by applying the U.S. medical code CPT. Jaehoon Jeong, CEO of Aidot, said, “Through artificial intelligence, Aidot will enable many people to enjoy medical benefits regardless of medical barriers and continue to develop products and solutions to improve human health.”

Aidot Booth can be found at the South Hall Level 3 – 3747 – First Time Exhibitor Pavilion

VIEW FLOOR PLAN
Jesus Randy RIvera

A graduate of the esteemed Far Eastern University - Nicanor Reyes Medical Foundation, Dr. Rivera is a radiation oncologist by profession, equipped with specialized training in IMRT and prostate brachytherapy. His expertise has been honed through experiences at renowned institutions such as the MD Anderson Cancer Center in Texas and the Chicago Prostate Center in Chicago, among others. However, his contributions extend far beyond the clinical realm. Dr Bogs Rivera is the visionary founder of CerviQ, an advocacy group passionately committed to eradicating cervical cancer in the Philippines. Through innovative screening programs, leveraging artificial intelligence and remote diagnostic technologies, CerviQ strives to increase access to cervical cancer screenings in communities, facilitating early detection and potentially life-saving interventions. His leadership not only empowers healthcare professionals but also empowers communities, enabling barangay health workers to conduct screenings efficiently and accurately, with rapid turnaround times for results. Dr. Bogs Rivera embodies the intersection of medical expertise and humanitarianism, dedicated to improving healthcare outcomes and championing the cause of public health in the Philippines.